Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Carmot Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10938
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company that discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company provides product portfolio such as encompasses investigational candidates in preclinical trials: peptide-small molecule hybrid compounds that target Nonalcoholic Steatohepatitis NASH. It offers products such as protein-protein interactions NEMO and IKK for the treatment of cancer and inflammation; and GLP-1R and GIPR for treating Type 2 diabetes and obesity, among others. Carmot Therapeutics proprietary technology, Chemotype Evolution applies to identify and optimize innovative drugs for various therapeutic areas. The company works in collaboration with research institutions and companies such as Amgen Inc and Genentech for discovery of new drugs. Carmot Therapeutics is headquartered in Berkeley, California, the US.

Carmot Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Carmot Therapeutics Raises USD15 Million in Series B Financing 10
Carmot Therapeutics Raises USD10.8 Million in Venture Financing 11
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 12
Licensing Agreements 13
Amgen Enters into Licensing Agreement with Carmot Therapeutics 13
Amgen Expands its Licensing Agreement with Carmot Therapeutics 14
Genentech Enters into Licensing Agreement with Carmot Therapeutics 15
Carmot Therapeutics Inc – Key Competitors 16
Carmot Therapeutics Inc – Key Employees 17
Carmot Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carmot Therapeutics Raises USD15 Million in Series B Financing 10
Carmot Therapeutics Raises USD10.8 Million in Venture Financing 11
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 12
Amgen Enters into Licensing Agreement with Carmot Therapeutics 13
Amgen Expands its Licensing Agreement with Carmot Therapeutics 14
Genentech Enters into Licensing Agreement with Carmot Therapeutics 15
Carmot Therapeutics Inc, Key Competitors 16
Carmot Therapeutics Inc, Key Employees 17
Carmot Therapeutics Inc, Other Locations 18

List of Figures
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …
  • Kellwood Company, LLC:企業の戦略・SWOT・財務情報
    Kellwood Company, LLC - Strategy, SWOT and Corporate Finance Report Summary Kellwood Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Glanbia plc:企業のM&A・事業提携・投資動向
    Glanbia plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glanbia plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Myriad Genetics Inc (MYGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • Matra Petroleum Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Matra Petroleum Plc (Matra Petroleum), formerly Ming Resources, is an independent oil and gas exploration and production company that acquires, explores, develops, and produces oil and gas properties in the US. The company owns 27 leases located in the Texas Panhandle region covering an area …
  • Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Abramson Cancer Center (Abramson) formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include …
  • JRI Orthopaedics Ltd:製品パイプライン分析
    Summary JRI Orthopaedics Ltd (JRI), a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopaedic implants and surgical instruments. The company develops products for joint replacement, repair and reconstruction. It offers products for shoulder and knee arthoplasty, besides custom …
  • Motiva Enterprises LLC:企業の戦略的SWOT分析
    Motiva Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Apoteket AB:企業の戦略的SWOT分析
    Apoteket AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kier Group plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Smiths Group Plc (SMIN):医療機器:M&Aディール及び事業提携情報
    Summary Smiths Group Plc (Smiths Group) is a diversified technology company. It offers critical solutions for energy and process industries, medical devices and consumables, devices for detection and identification of security threats and contraband, solutions for high speed connectivity and compone …
  • FAR Ltd (FAR):石油・ガス:M&Aディール及び事業提携情報
    Summary FAR Ltd (FAR), formerly First Australian Resources NL, is an independent oil and gas company that offers acquisition, exploration, production and development of oil and natural gas properties. The company has oilfield appraisal wells and exploration assets in West and East Africa. It operate …
  • Genetic Analysis AS:医療機器:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Manhattan Associates Inc (MANH):企業の財務・戦略的SWOT分析
    Manhattan Associates Inc (MANH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Environmental Tectonics Corp:企業の戦略・SWOT・財務分析
    Environmental Tectonics Corp - Strategy, SWOT and Corporate Finance Report Summary Environmental Tectonics Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Actelion Ltd:企業の戦略・SWOT・財務情報
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Gleiss Lutz Hootz Hirsch GmbH:企業の戦略的SWOT分析
    Gleiss Lutz Hootz Hirsch GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • GCL System Integration Technology Co Ltd (002506):電力:M&Aディール及び事業提携情報
    Summary GCL System Integration Technology Co Ltd (GCL System Integration), formerly Shanghai Chaori Solar Energy Science & Technology Co Ltd, a subsidiary of Golden Concord Holdings Ltd, is a renewable energy company that offers clean and sustainable power production services. The company's products …
  • Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析
    Summary Dermira Inc (Dermira) is a bio-pharmaceutical company which concentrates on the development and commercialization of novel therapies for the treatment of chronic skin conditions. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆